American Trust’s AstraZeneca AZN Stock Holding History

American Trust’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$223K	Sell	1,133 -19	-2%	-$3.66K	0.02%	287
2025 Q4	$212K	Buy	+1,152	New	+$202K	0.02%	305
2025 Q1	–	Sell	-2,030	Closed	-$266K	–	138
2024 Q4	$266K	Sell	2,030 -21	-1%	-$2.94K	0.02%	247
2024 Q3	$320K	Sell	2,051 -143	-7%	-$23.1K	0.03%	176
2024 Q2	$342K	Buy	2,194 +479	+28%	+$72.1K	0.03%	156
2024 Q1	$232K	Sell	1,715 -518	-23%	-$68.6K	0.02%	239
2023 Q4	$301K	Buy	2,233 +73	+3%	+$9.49K	0.02%	207
2023 Q3	$293K	Sell	2,160 -350	-14%	-$47.8K	0.02%	213
2023 Q2	$359K	Sell	2,510 -70	-3%	-$10.3K	0.02%	263
2023 Q1	$358K	Sell	2,580 -268	-9%	-$36.1K	0.02%	269
2022 Q4	$386K	Buy	+2,848	New	+$357K	0.04%	265

Other funds holding AZN

Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

VAM

Vanguard Asset Management London, Ec4n 8af $117B AUM

American Trust's AZN Position: Q1 2026 in Review

American Trust reduced its AstraZeneca (AZN) stake by 1.6% in Q1 2026, selling an estimated $3.66K and leaving 1,133 shares worth $223K. The position accounts for 0.02% of the portfolio, ranked #287.

American Trust first reported a position in AZN in Q4 2022 and has held it in 11 quarters since. The position peaked at $386K in Q4 2022. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

American Trust held 1,133 shares of AstraZeneca worth $223K as of Q1 2026.
American Trust sold 19 AstraZeneca shares in Q1 2026, an estimated $3.66K.
AstraZeneca made up 0.02% of American Trust's portfolio in Q1 2026, its #287 holding.
American Trust first reported a position in AstraZeneca in Q4 2022 and has held it in 11 quarters since.
American Trust's AstraZeneca position peaked at $386K in Q4 2022.
1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on American Trust's 13F filing for Q1 2026, filed 1 May 2026.